(文/解红娟 编辑/张广凯） 连续两次IPO折戟让卓正医疗的上市耐心备受考验，为规避2026年底对赌协议到期的风险，这家私立医疗机 构正在紧锣密鼓推进第三次IPO闯关。 近日，卓正医疗再度向港交所递交招股书，由海通国际与浦银国际担任联席保荐人。根据弗若斯特沙利文的 资料，以2024年的收入计，卓正医疗是中国第三大私立中高端综合医疗服务机构，市场份额为2.0%。 在此之前，卓正医疗上市征程已两度遇挫。回溯上市历程，卓正医疗首次闯关始于2024年5月16日，根据港交 所"招股书递交后6个月未完成上市流程自动失效"的规则，该份招股书于当年11月16日按期失效，首次IPO宣 告折戟。2025年3月18日，卓正医疗卷土重来递交第二份招股书，但同样因未能在6个月有效期内完成流程， 于9月18日再度失效。 距离第二份招股书失效不到两个月，卓正医疗再次提交招股书。而卓正医疗之所以对冲刺IPO如此急迫，或 许与前置投资者的对赌协议约束有关。 有媒体报道，招股书明确显示，授予IPO前投资者的赎回权已于本公司首次提交IPO日期前暂停。根据日期为 2025年3月17日的股东协议，仅在本公司的IPO被撤回、拒绝或失效；或2026年12 ...

每日经济新闻 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前核实。据此操作，风险自担。 每经AI快讯，有投资者在投资者互动平台提问：尊敬的董秘您好，请问阿里巴巴目前持有公司股份 吗？另外公司的养老产品主要有哪些，有养老机器人或者医疗机器人相关的产品或者中间产品吗？ 漱玉平民（301017.SZ）12月3日在投资者互动平台表示，阿里健康科技（中国）有限公司为持有公司 6.67%股份的股东。在养老产品方面，公司作为医药零售连锁企业，主要通过与知名品牌合作，主要涵 盖慢病管理、中药饮片、保健食品及健康器械等服务及品类。关于养老或医疗机器人，公司目前暂未开 展相关业务。 （记者 曾健辉） ...

Core Viewpoint - Southbound funds reduced their holdings in iFlytek Medical Technology (02506.HK) by 5,550 shares on October 16, 2025, indicating a slight decrease in investor confidence in the short term [1]. Group 1: Southbound Fund Activity - In the last five trading days, southbound funds increased their holdings on three days, with a total net increase of 85,400 shares [1]. - Over the past 20 trading days, there were 16 days of net increases, totaling 253,400 shares [1]. - As of now, southbound funds hold 3,710,600 shares of iFlytek Medical Technology, accounting for 4.79% of the company's total issued ordinary shares [1]. Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [2]. - The company's business lines include grassroots medical services (intelligent medical assistants and chronic disease management), hospital services (smart hospital solutions and diagnostic assistants), and patient services (smart hospital patient services and post-discharge management) [2]. - The regional management platform solutions include smart health solutions and smart medical insurance [2].

Group 1 - The core point of the article is that the China Securities Regulatory Commission has accepted the overseas listing application of QingSong Health Corporation, allowing the company to issue up to 36,496,400 ordinary shares on the Hong Kong Stock Exchange [1] - QingSong Health Corporation is a comprehensive health service enterprise focused on digital health management and insurance technology, covering areas such as health insurance, medical assistance, chronic disease management, and health service network construction [1] - The company aims to provide users with convenient and affordable health protection and services [1]

Core Insights - The China Securities Regulatory Commission has officially accepted the filing for the overseas listing of QingSong Health Corporation, marking a significant step in the company's progress towards an IPO in Hong Kong [1] Company Overview - QingSong Health Corporation is a comprehensive health service enterprise focused on digital health management and insurance technology, offering services in health insurance, medical assistance, chronic disease management, and health service network construction [1] Listing Details - The company plans to issue no more than 36,496,400 ordinary shares on the main board of the Hong Kong Stock Exchange [1] - This filing indicates substantial progress in the company's journey towards public offering and listing [1]

Group 1 - The core point of the article is that QingSong Health Corporation has received formal acceptance of its overseas listing application from the China Securities Regulatory Commission, marking a significant step in its process to go public in Hong Kong [1] - QingSong Health Corporation plans to issue no more than 36,496,400 ordinary shares on the main board of the Hong Kong Stock Exchange [1] - The company focuses on digital health management and insurance technology, providing services in health insurance, medical assistance, chronic disease management, and health service network construction [1] Group 2 - The listing application signifies substantial progress in QingSong Health Corporation's efforts to establish a public offering and listing [1] - The company aims to offer convenient and affordable health protection and services to its users [1]

Core Insights - Health 160 International Limited has successfully passed the listing hearing on the Hong Kong Stock Exchange, marking a significant milestone for the digital health sector in China [1] - The company, established in 2005, is one of the early entrants in the "Internet + Healthcare" space, offering a comprehensive service system that includes appointment booking, online consultations, health management, pharmaceutical e-commerce, and medical information technology [1] - Health 160 has connected with over a thousand large hospitals nationwide, boasting over 100 million registered users and an average daily service volume of one million, showcasing its competitive advantage in digital healthcare services [1] Company Plans - The successful listing hearing is a validation of Health 160's business model and growth prospects, providing strong capital support for future expansion [1] - The company plans to use the raised funds for technology research and development, market expansion, and strategic investments, particularly in AI-assisted diagnosis, chronic disease management, and smart hospital solutions [1] Industry Impact - Analysts suggest that Health 160's listing will accelerate the consolidation of the digital health industry, directing more resources towards leading platforms and enhancing the accessibility and efficiency of public health services [1]

Group 1 - The healthcare industry in China is poised to become one of the largest industries due to factors such as aging population, chronic disease prevalence, rising health awareness, and the national health strategy [3][4] - The shift from a "disease-centered" approach to a "health-centered" model is necessary, emphasizing preventive care and comprehensive health management [4][5] - Traditional healthcare business models are undergoing disruptive reconstruction, with a need for new value creation models and organizational structures [5][6] Group 2 - The healthcare industry is returning to its public welfare roots, with a focus on genuine health outcomes rather than profit-driven motives [6][7] - AI and emerging technologies are expected to create a divide in the industry, favoring institutions that can integrate technology effectively [7][8] - Market-oriented AI applications are more sustainable than government procurement models, driving efficiency and innovation in healthcare services [8][9] Group 3 - Commercial health insurance is becoming a crucial component of the multi-tiered healthcare system, with potential market value exceeding trillions [9][10] - Private healthcare institutions are expected to undergo structural upgrades rather than decline, focusing on quality over quantity [10][11] - Public hospitals are facing increased scrutiny and cost control measures, leading to heightened survival pressures for third-party service providers [11][12] Group 4 - There is a fundamental shift in public health consciousness, moving from treatment to prevention and self-management, particularly among younger and older demographics [12]